Malik Ibrahim, Turk John, Mancuso David J, Montier Laura, Wohltmann Mary, Wozniak David F, Schmidt Robert E, Gross Richard W, Kotzbauer Paul T
Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Am J Pathol. 2008 Feb;172(2):406-16. doi: 10.2353/ajpath.2008.070823. Epub 2008 Jan 17.
Mutations in the PLA2G6 gene, which encodes group VIA calcium-independent phospholipase A2 (iPLA(2)beta), were recently identified in patients with infantile neuroaxonal dystrophy (INAD) and neurodegeneration with brain iron accumulation. A pathological hallmark of these childhood neurodegenerative diseases is the presence of distinctive spheroids in distal axons that contain accumulated membranes. We used iPLA(2)beta-KO mice generated by homologous recombination to investigate neurodegenerative consequences of PLA2G6 mutations. iPLA(2)beta-KO mice developed age-dependent neurological impairment that was evident in rotarod, balance, and climbing tests by 13 months of age. The primary abnormality underlying this neurological impairment was the formation of spheroids containing tubulovesicular membranes remarkably similar to human INAD. Spheroids were strongly labeled with anti-ubiquitin antibodies. Accumulation of ubiquitinated protein in spheroids was evident in some brain regions as early as 4 months of age, and the onset of motor impairment correlated with a dramatic increase in ubiquitin-positive spheroids throughout the neuropil in nearly all brain regions. Furthermore accumulating ubiquitinated proteins were observed primarily in insoluble fractions of brain tissue, implicating protein aggregation in this pathogenic process. These results indicate that loss of iPLA(2)beta causes age-dependent impairment of axonal membrane homeostasis and protein degradation pathways, leading to age-dependent neurological impairment. iPLA(2)beta-KO mice will be useful for further studies of pathogenesis and experimental interventions in INAD and neurodegeneration with brain iron accumulation.
编码ⅥA组钙非依赖性磷脂酶A2(iPLA(2)β)的PLA2G6基因突变,最近在患有婴儿神经轴索性营养不良(INAD)和脑铁沉积神经退行性疾病的患者中被发现。这些儿童神经退行性疾病的一个病理特征是在含有积聚膜的远端轴突中存在独特的球状体。我们使用通过同源重组产生的iPLA(2)β基因敲除小鼠来研究PLA2G6基因突变的神经退行性后果。iPLA(2)β基因敲除小鼠出现了年龄依赖性的神经功能障碍,在13月龄时的转棒试验、平衡试验和攀爬试验中表现明显。这种神经功能障碍的主要潜在异常是形成了含有微管泡状膜的球状体,与人类INAD非常相似。球状体被抗泛素抗体强烈标记。早在4月龄时,在一些脑区的球状体中泛素化蛋白的积累就很明显,运动障碍的出现与几乎所有脑区整个神经纤维网中泛素阳性球状体的急剧增加相关。此外,主要在脑组织的不溶性部分观察到泛素化蛋白的积累,这表明在这个致病过程中存在蛋白质聚集。这些结果表明,iPLA(2)β的缺失导致轴突膜稳态和蛋白质降解途径的年龄依赖性损害,从而导致年龄依赖性神经功能障碍。iPLA(2)β基因敲除小鼠将有助于进一步研究INAD和脑铁沉积神经退行性疾病的发病机制和实验干预。